SWEDEPAD beskrivs i en artikel i den internationella forsknings- och innovationstidskriften International Innovations senaste upplaga.

I artikeln beskriver Joakim Nordanstig bla. bakgrunden till studien.

-"Drug-eluting endovascular tools are currently intensively marketed towards doctors and hospitals involved in endovascular interventions of PAD. To my mind, the technology is very promising, but also imposes substantially higher costs for the healthcare system. In an on-going health technology assessment, we identified that solid, high-quality evidence for the application of drug-elution concepts in PAD is largely lacking."

 Läs hela artikeln här:


Tillbaka till toppen